News Sentiment

HKPD sentiment intelligence

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 43 Balanced news tone 21 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Distribution Read-through group
Latest close 0.45 Week of 10 Jul 2026
Weighted tone 43/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

85/100 classification confidence.

Company focus 21

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+2.4% over one week, +8.4% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

Hong Kong Pharma Digital Technology Holdings Ltd

Market Reaction

Balanced read

68/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 85/100 classification
One-week reaction 2.4% Price confirming higher
Trend fit Trend inactive 8.4% over four weeks
Fair value -57.6% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 3
Neutral 9
Negative 9

Relevance

Why the article matched

Direct first
Direct company coverage 21
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
TradingKey 5
Stock Titan 4
FinancialContent 1
Intellectia AI 1
The Globe and Mail 1
The Manila Times 1
Simply Wall St 1
MSN 1

Event Lens

What the news is about

Classified themes
Market update 15
Earnings 4
Macro sensitivity 1
Regulatory and legal 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-21 of 21
TradingKey Direct company coverage

Hong Kong Pharma Digital Technology Holdings Ltd

This article provides a technical analysis of Hong Kong Pharma Digital Technology Holdings Ltd (HKPD), including its support, resistance levels, indicators, and moving averages. The analysis presents a summarized view of buy, sell, and neutral signals based on various technical i

Tone
Negative 29/100
Event
Market update
Published
25 Jun 2026 13:40
Source
TradingKey
TradingKey Direct company coverage

Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) Earnings Forecast: Future EPS & Revenue Growth Estimates — TradingKey

The TradingKey platform provides an overview of Hong Kong Pharma Digital Technology Holdings Ltd (HKPD), including its current stock price, market cap, and a general analysis framework. However, the section for earnings forecast, EPS, revenue, net profit, and EBIT indicates that

Tone
Negative 40/100
Event
Earnings
Published
18 Jun 2026 03:39
Source
TradingKey
TradingKey Direct company coverage

Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Hong Kong Pharma Digital Technology Holdings Ltd (HKPD), focusing on its P/E, P/B, and Fair Value. As of the report, relevant P/E, P/B, P/S, and P/CF data have not been disclosed by the company. The stock is currently trading at 0.40

Tone
Neutral 50/100
Event
Market update
Published
18 Jun 2026 01:39
Source
TradingKey
TradingKey Direct company coverage

Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) Institutional Confidence

This article from TradingKey focuses on the institutional confidence in Hong Kong Pharma Digital Technology Holdings Ltd (HKPD). It presents a list of institutional shareholders, their shareholdings, and changes in their positions. The company's stock performance shows a recent d

Tone
Negative 33/100
Event
Market update
Published
18 Jun 2026 01:39
Source
TradingKey
TradingKey Direct company coverage

Hong Kong Pharma Digital Technology Holdings Ltd (HKPD) Financial Health: Profitability & Balance Sheet Analysis

This article from TradingKey analyzes the financial health of Hong Kong Pharma Digital Technology Holdings Ltd (HKPD), focusing on profitability and balance sheet aspects. It notes that relevant financial data regarding cash, assets, liabilities, free cash flow, revenue, operatin

Tone
Negative 33/100
Event
Earnings
Published
18 Jun 2026 01:39
Source
TradingKey
Stock Titan Direct company coverage

[Form 3] Cellyan Biotechnology Co., Ltd Initial Statement of Beneficial Ownership

Cellyan Biotechnology Co., Ltd director Wong Lap Sun has filed an initial Form 3, reporting beneficial ownership of 18,468 Class A Ordinary Shares. This filing establishes his direct holdings in the company and serves as a baseline for future insider transactions, without indicat

Tone
Neutral 50/100
Event
Market update
Published
10 Jun 2026 19:39
Source
Stock Titan
FinancialContent Direct company coverage

Articles from Hong Kong Pharma Digital Technology Holdings Ltd

Hong Kong Pharma Digital Technology Holdings Limited announced that all proposals were duly passed at its 2025 annual meeting of stockholders held on December 12, 2025. The company, a leading provider of over-the-counter pharmaceutical cross-border e-commerce supply chain service

Tone
Positive 71/100
Event
Macro sensitivity
Published
27 Apr 2026 12:40
Source
FinancialContent
Stock Titan Direct company coverage

12.5M shares for resale — Cellyan Biotechnology (NASDAQ: HKPD)

Cellyan Biotechnology (NASDAQ: HKPD) has filed an F-1 registration statement for the resale of up to 12.5 million Class A Ordinary Shares by existing shareholders from a March 2026 private placement. The company will not receive any proceeds from these sales, which will be conduc

Tone
Neutral 50/100
Event
Market update
Published
27 Mar 2026 19:39
Source
Stock Titan
Stock Titan Direct company coverage

Cellyan Biotechnology (HKPD) completes $6.5M private unit financing

Cellyan Biotechnology (HKPD) has successfully completed a private placement, raising approximately $6.5 million by selling 12,499,986 units at $0.52 each. Each unit includes a Class A ordinary share and two three-year warrants with a low exercise price of $0.01 per share. The pro

Tone
Neutral 50/100
Event
Market update
Published
27 Mar 2026 09:39
Source
Stock Titan
Intellectia AI Direct company coverage

HKPD Stock News Today | Earnings, Events & Price Alerts

This page provides a consolidated view of news and events related to HKPD stock, including recent corporate announcements and past financial news. Key updates include Nasdaq non-compliance warnings for Cellyan Biotechnology (HKPD), capital restructuring approvals, and previous IP

Tone
Negative 40/100
Event
Earnings
Published
02 Mar 2026 21:51
Source
Intellectia AI
The Globe and Mail Direct company coverage

Cellyan Biotechnology Hit With Nasdaq Bid-Price Deficiency Notice, Shares Remain Listed

Cellyan Biotechnology Co., Ltd (formerly Hong Kong Pharma Digital Technology Holdings Ltd.) received a Nasdaq bid-price deficiency notice because its Class A ordinary shares traded below US$1.00 for 30 consecutive business days. The company has 180 calendar days to regain complia

Tone
Negative 20/100
Event
Market update
Published
18 Jan 2026 12:57
Source
The Globe and Mail
The Manila Times Direct company coverage

Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Bid Price Deficiency

Cellyan Biotechnology Co., Ltd (Nasdaq: HKPD) has received a notice from Nasdaq regarding non-compliance with the minimum bid price requirement. The company's share price was below $1.00 for 30 consecutive business days. Cellyan Biotechnology Co., Ltd has 180 calendar days to reg

Tone
Negative 29/100
Event
Market update
Published
17 Jan 2026 21:58
Source
The Manila Times
Stock Titan Direct company coverage

Cellyan Biotechnology (NASDAQ: HKPD) warned on bid price rule compliance

Cellyan Biotechnology (NASDAQ: HKPD) has received a notice from Nasdaq regarding its non-compliance with the minimum bid price requirement. The company's Class A ordinary shares traded below US$1.00 for 30 consecutive business days, triggering the warning. Cellyan Biotechnology h

Tone
Negative 29/100
Event
Market update
Published
16 Jan 2026 20:10
Source
Stock Titan
Simply Wall St Direct company coverage

Cellyan Biotechnology (Nasdaq:HKPD) - Stock Analysis

This Simply Wall St analysis provides a comprehensive overview of Cellyan Biotechnology (Nasdaq:HKPD), an investment holding company involved in OTC pharmaceutical business in Hong Kong and Mainland China. The report covers its financials, including a market cap of US$7.3m, curre

Tone
Negative 29/100
Event
Market update
Published
03 Jan 2026 20:53
Source
Simply Wall St
MSN Direct company coverage

Hong Kong Pharma Digital Technology Announces Board Changes

The article "Hong Kong Pharma Digital Technology Announces Board Changes" contains no substantive content beyond its title. No further information about the board changes, the company, or relevant dates is provided in the input.

Tone
Neutral 50/100
Event
Market update
Published
31 Dec 2025 00:09
Source
MSN
富途牛牛 Direct company coverage

Hong Kong Pharma Digital Announced Results of 2025 Annual Meeting of Stockholders

Hong Kong Pharma Digital Technology Holdings Limited (NASDAQ: HKPD) announced that all proposals presented at its 2025 annual meeting of stockholders on December 12, 2025, were duly passed. Key approvals include the re-election of five directors, ratification of an independent ac

Tone
Positive 62/100
Event
Earnings
Published
22 Dec 2025 03:22
Source
富途牛牛